Clinical Trial · NCT07272772

Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients With Colon Cancer

Overview

The objective of this prospective study is to evaluate diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer. The aim is to evaluate the sensitivity and specificity of 18F-FAPI-74 in detection of local lymph node metastasis and distant metastasis in patient level in patients with colon cancer in primary staging and when suspected recurrence. 100 patients with colon cancer are enrolled and PET/CT studies are performed with the novel 18F-FAPI-74 tracer. The data will be collected between 2024-2026.

Sponsor

Turku University Hospital

Phase

Phase 2/3

Contacts

Saila Kauhanen

saila.kauhanen@utu.fi

+358503017010

ClinicalTrials.gov

NCT07272772

Drug / Compound

18F-FAPI-74

Isotope(s):
Target(s):
  • FAP
Ligand Class: Small Molecules
Chelator: NOTA